Publication:
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis

dc.contributor.authorAl Khleifat, Ahmad
dc.contributor.authorIacoangeli, Alfredo
dc.contributor.authorvan Vugt, Joke J F A
dc.contributor.authorBowles, Harry
dc.contributor.authorMoisse, Matthieu
dc.contributor.authorZwamborn, Ramona A J
dc.contributor.authorvan der Spek, Rick A A
dc.contributor.authorShatunov, Aleksey
dc.contributor.authorCooper-Knock, Johnathan
dc.contributor.authorTopp, Simon
dc.contributor.authorByrne, Ross
dc.contributor.authorGellera, Cinzia
dc.contributor.authorLópez-Alonso, Victoria
dc.contributor.authorJones, Ashley R
dc.contributor.authorOpie-Martin, Sarah
dc.contributor.authorVural, Atay
dc.contributor.authorCampos, Yolanda
dc.contributor.authorvan Rheenen, Wouter
dc.contributor.authorKenna, Brendan
dc.contributor.authorVan Eijk, Kristel R
dc.contributor.authorKenna, Kevin
dc.contributor.authorWeber, Markus
dc.contributor.authorSmith, Bradley
dc.contributor.authorFogh, Isabella
dc.contributor.authorSilani, Vincenzo
dc.contributor.authorMorrison, Karen E
dc.contributor.authorDobson, Richard
dc.contributor.authorvan Es, Michael A
dc.contributor.authorMcLaughlin, Russell L
dc.contributor.authorVourc'h, Patrick
dc.contributor.authorChio, Adriano
dc.contributor.authorCorcia, Philippe
dc.contributor.authorde Carvalho, Mamede
dc.contributor.authorGotkine, Marc
dc.contributor.authorPanades, Monica P
dc.contributor.authorMora, Jesus S
dc.contributor.authorShaw, Pamela J
dc.contributor.authorLanders, John E
dc.contributor.authorGlass, Jonathan D
dc.contributor.authorShaw, Christopher E
dc.contributor.authorBasak, Nazli
dc.contributor.authorHardiman, Orla
dc.contributor.authorRobberecht, Wim
dc.contributor.authorVan Damme, Philip
dc.contributor.authorvan den Berg, Leonard H
dc.contributor.authorVeldink, Jan H
dc.contributor.authorAl-Chalabi, Ammar
dc.contributor.funderWellcome Trust
dc.contributor.funderUnión Europea. Comisión Europea. 7 Programa Marco
dc.contributor.funderUnión Europea. Comisión Europea. H2020
dc.contributor.funderUnión Europea. Fondo Social Europeo (ESF/FSE)
dc.contributor.funderResearch Foundation - Flanders
dc.contributor.funderKatholieke Universiteit Leuven (Bélgica)
dc.contributor.funderScience Foundation Ireland
dc.contributor.funderAmyotrophic Lateral Sclerosis Association (Estados Unidos)es_ES
dc.contributor.funderNIH - National Institute of Neurological Disorders and Stroke (NINDS) (Estados Unidos)
dc.date.accessioned2023-04-27T08:52:15Z
dc.date.available2023-04-27T08:52:15Z
dc.date.issued2022-01-28
dc.description.abstractThere is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability estimates of up to 60%. Both Mendelian and small effect variants have been identified, but in common with other conditions, such variants only explain a little of the heritability. Genomic structural variation might account for some of this otherwise unexplained heritability. We therefore investigated association between structural variation in a set of 25 ALS genes, and ALS risk and phenotype. As expected, the repeat expansion in the C9orf72 gene was identified as associated with ALS. Two other ALS-associated structural variants were identified: inversion in the VCP gene and insertion in the ERBB4 gene. All three variants were associated both with increased risk of ALS and specific phenotypic patterns of disease expression. More than 70% of people with respiratory onset ALS harboured ERBB4 insertion compared with 25% of the general population, suggesting respiratory onset ALS may be a distinct genetic subtype.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipSamples used in this research were in part obtained from the UK National DNA Bank for MND Research, funded by the MND Association and the Wellcome Trust. We thank people with MND and their families for their participation in this project. We acknowledge sample management undertaken by Biobanking Solutions funded by the Medical Research Council at the Centre for Integrated Genomic Medical Research, University of Manchester. This research was funded in whole, or in part, by the Wellcome Trust [Grant number]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. The authors acknowledge use of the research computing facility at King’s College London, Rosalind (https://rosalind.kcl.ac.uk), which is delivered in partnership with the National Institute for Health Research (NIHR) Biomedical Research Centres at South London & Maudsley and Guy’s & St. Thomas’ NHS Foundation Trusts, and partfunded by capital equipment grants from the Maudsley Charity (award 980) and Guy’s & St. Thomas’ Charity (TR130505). The views expressed are those of the author (s) and not necessarily those of the NHS, the NIHR, King’s College London, or the Department of Health and Social Care. National. The authors acknowledge Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The authors acknowledge Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation and Wellcome Trust. A.A.K. is funded by The Motor Neurone Disease Association (MNDA), NIHR Maudsley Biomedical Research Centre and and ALS Association Milton Safenowitz Research Fellowship. This project was funded by the MND Association and the Wellcome Trust. This is an EU Joint Programme-Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council (MR/L501529/1 and MR/R024804/1) and Economic and Social Research Council (ES/L008238/1)). A.A.C. is an NIHR Senior Investigator. C.E.S. and A.A.C. receive salary support from the National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The work leading up to this publication was funded by the European Community’s Health Seventh Framework Program (FP7/2007–2013; grant agreement number 259867) and Horizon 2020 Program (H2020-PHC-2014-two-stage; grant agreement number 633413). This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 772376 - EScORIAL. The collaboration project is co-funded by the PPP Allowance made available by Health~Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. Project MinE Belgium was supported by a grant from IWT, the Belgian ALS Liga and a grant from Opening the Future Fund (KU Leuven). PVD holds a senior clinical investigatorship of FWO-Vlaanderen and is supported by E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the ALS Liga België and the KU Leuven funds “Een Hart voor ALS”, “Laeversfonds voor ALS Onderzoek” and the “Valéry Perrier Race against ALS Fund”. R.L.McL. is supported by Science Foundation Ireland (17/CDA/4737). MinE USA is funded by the US ALS Association. We thank the patients and families from the Emory ALS Clinic participating in this research. Funding was provided by US National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) (R01NS073873, J.E.L.) and the American ALS Association (J.E.L.).es_ES
dc.format.number1es_ES
dc.format.page8es_ES
dc.format.volume7es_ES
dc.identifier.citationNPJ Genom Med. 2022 Jan 28;7(1):8.es_ES
dc.identifier.doi10.1038/s41525-021-00267-9es_ES
dc.identifier.e-issn2056-7944es_ES
dc.identifier.journalNPJ genomic medicinees_ES
dc.identifier.pubmedID35091648es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15907
dc.language.isoenges_ES
dc.publisherNature Publishing Group
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/259867/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/633413/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/772376/EUes_ES
dc.relation.publisherversionhttps://doi.org/10.1038/s41525-021-00267-9es_ES
dc.repisalud.centroISCIII::Unidad Funcional de Investigación de Enfermedades Crónicas (UFIEC)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectGenome sequenceses_ES
dc.subjectAmyotrophic lateral sclerosis (ALS)es_ES
dc.titleStructural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosises_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationb280441c-10a0-4dbd-a8ca-8274086ba2a5
relation.isAuthorOfPublication3caca5d8-64f7-4512-8995-50b151f39fe5
relation.isAuthorOfPublication.latestForDiscoveryb280441c-10a0-4dbd-a8ca-8274086ba2a5
relation.isFunderOfPublication1b78a4d7-62cf-4b05-9b61-0343816c4c56
relation.isFunderOfPublication453a1d63-c349-4a0e-b0f2-f4edba065c75
relation.isFunderOfPublicationa418cf3b-f427-4376-a75f-01dba9bb944f
relation.isFunderOfPublication36ca2ebf-c6c3-4f53-8618-500af224a277
relation.isFunderOfPublication444372a3-1d97-4ac2-a291-e5f35b507745
relation.isFunderOfPublication6fa836a0-60e1-4ba6-8293-423f452fbbcf
relation.isFunderOfPublication90c15883-5c89-4576-9d05-5eebfc41784b
relation.isFunderOfPublicationf8588ec3-d7ff-42fc-a921-1ce806518414
relation.isFunderOfPublication.latestForDiscovery1b78a4d7-62cf-4b05-9b61-0343816c4c56
relation.isPublisherOfPublication301fb00e-338e-4f8c-beaa-f9d8f4fefcc0
relation.isPublisherOfPublication.latestForDiscovery301fb00e-338e-4f8c-beaa-f9d8f4fefcc0

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
StructuralVariationAnalysisGenome_2022.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Supplementary1_StructuralVariationAnalysisGenome_2022.pdf
Size:
800.98 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material 1
Loading...
Thumbnail Image
Name:
Supplementary2_StructuralVariationAnalysisGenome_2022.pdf
Size:
73.07 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material 2